242 related articles for article (PubMed ID: 12956431)
21. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
Land WG; Gutmann T; Daar AS
Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
[TBL] [Abstract][Full Text] [Related]
22. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology.
Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT
Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393
[TBL] [Abstract][Full Text] [Related]
23. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
[TBL] [Abstract][Full Text] [Related]
24. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
[TBL] [Abstract][Full Text] [Related]
25. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
26. Increased lung allograft failure in patients with HLA-specific antibody.
Girnita AL; McCurry KR; Zeevi A
Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
[TBL] [Abstract][Full Text] [Related]
27. Pathology of lung transplantation.
Stewart S
Semin Diagn Pathol; 1992 Aug; 9(3):210-9. PubMed ID: 1523359
[TBL] [Abstract][Full Text] [Related]
28. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance.
Wadia PP; Tambur AR
Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264
[TBL] [Abstract][Full Text] [Related]
29. Immune mechanisms of lung allograft rejection.
Snyder LD; Palmer SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):534-43. PubMed ID: 17072801
[TBL] [Abstract][Full Text] [Related]
30. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
31. Morphologic features of chronic rejection in kidney and less commonly transplanted organs.
Sibley RK
Clin Transplant; 1994 Jun; 8(3 Pt 2):293-8. PubMed ID: 8061371
[TBL] [Abstract][Full Text] [Related]
32. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
[TBL] [Abstract][Full Text] [Related]
33. Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside.
Terness P; Kleist C; Simon H; Sandra-Petrescu F; Ehser S; Chuang JJ; Mohr E; Jiga L; Greil J; Opelz G
Hum Immunol; 2009 Jul; 70(7):506-12. PubMed ID: 19393276
[TBL] [Abstract][Full Text] [Related]
34. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.
Merani S; Truong WW; Hancock W; Anderson CC; Shapiro AM
Cell Transplant; 2006; 15(4):295-309. PubMed ID: 16898223
[TBL] [Abstract][Full Text] [Related]
35. Optimizing post-transplant outcomes in lung transplantation.
McCartney JG; Meyer KC
Expert Rev Respir Med; 2008 Apr; 2(2):183-99. PubMed ID: 20477248
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to self-antigens (autoimmunity) in allograft rejection.
Ramachandran S; Subramanian V; Mohanakumar T
Clin Transpl; 2012; ():261-72. PubMed ID: 23721031
[TBL] [Abstract][Full Text] [Related]
37. Prevention of acute lung allograft rejection in rat by the janus kinase 3 inhibitor, tyrphostin AG490.
Higuchi T; Shiraishi T; Shirakusa T; Hirayama S; Shibaguchi H; Kuroki M; Hiratuka M; Yamamoto S; Iwasaki A; Kuroki M
J Heart Lung Transplant; 2005 Oct; 24(10):1557-64. PubMed ID: 16210130
[TBL] [Abstract][Full Text] [Related]
38. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
39. Nicotine attenuates macrophage infiltration in rat lung allografts.
Hirschburger M; Zakrzewicz A; Kummer W; Padberg W; Grau V
J Heart Lung Transplant; 2009 May; 28(5):493-500. PubMed ID: 19416779
[TBL] [Abstract][Full Text] [Related]
40. Acute lung transplant rejection is associated with localized increase in T-cell IFNgamma and TNFalpha proinflammatory cytokines in the airways.
Hodge G; Hodge S; Chambers D; Reynolds PN; Holmes M
Transplantation; 2007 Dec; 84(11):1452-8. PubMed ID: 18091521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
